Evidence map›Paper›PMID 38337759›Full record

ArticleDiagnostics (Basel, Switzerland)2024

NSCLC Digital PCR Panel Returns Low-Input Sample Results Where Sequencing Fails.

Leah Rowland Herdt, Paige Berroteran, Malini Rajagopalan, Bradley A Brown, Jerrod J Schwartz

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Leah Rowland HerdtChromaCode Inc., 2330 Faraday Ave, Carlsbad, CA 92008, USA.
Paige BerroteranChromaCode Inc., 2330 Faraday Ave, Carlsbad, CA 92008, USA.
Malini RajagopalanChromaCode Inc., 2330 Faraday Ave, Carlsbad, CA 92008, USA.
Bradley A BrownChromaCode Inc., 2330 Faraday Ave, Carlsbad, CA 92008, USA.
Jerrod J SchwartzChromaCode Inc., 2330 Faraday Ave, Carlsbad, CA 92008, USA.ORCID 0009-0001-4076-9178

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular diagnostics has drastically improved the survival rate of patients diagnosed with non-small cell lung cancer (NSCLC) over the last 10 years. Despite advancements in molecular testing, targeted therapies, and national guideline recommendations, more than half of NSCLC patients in the United States either never receive testing or patient care is not informed via molecular testing. Here, we sought to explore the relationship between DNA/RNA input, the molecular testing method, and test success rates. On a shared set of low-input reference test materials (

Indexed as

dPCRNGSNSCLCQNS

Identifiers

PMID38337759
PMCPMC10854965
OpenAlexW4391170093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.